Rogers News | finanzen.ch

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Aktion

Portfolio

Watchlist

20.11.23	Roche launches next-generation qPCR system to advance clinical needs in molecular diagnostics and address public health challenges (PR Newswire)
26.10.23	Roche collaborates with Ibex and Amazon Web Services to accelerate adoption of AI-enabled digital pathology solutions to help improve cancer diagnoses (PR Newswire)
05.09.23	Economist Impact report, Advancing the frontier of health and technology integration: The 2023 Digital Health Barometer highlights opportunities in digitalisation of healthcare (PR Newswire)
17.08.23	Roche launches a new addition to the cobas® connection modules, the CCM Vertical, helping to improve laboratory efficiency (PR Newswire)
08.08.23	New opportunities and persistent challenges revealed as organisations attempt more data-driven approaches to healthcare, says new report from Harvard Business Review Analytic Services (PR Newswire)
03.08.23	Roche expands long-term alliance with Sysmex (PR Newswire)
19.07.23	Roche to showcase next-generation diagnostic solutions at the American Association of Clinical Chemistry 2023 Clinical Lab Expo (PR Newswire)
27.06.23	Roche receives FDA clearance for additional Alzheimer's disease Cerebrospinal Fluid (CSF) assays, supporting timely diagnosis and treatment decision-making (PR Newswire)
17.05.23	Roche showcases commitment to advancing innovative diagnostic solutions at WorldLab-EuroMedLab (PR Newswire)
11.04.23	Roche introduces navify® Algorithm Suite, a digital library of medical algorithms that enhances clinical decision-making to optimise patient care (PR Newswire)
30.03.23	Rogers Corp. Announces Earnings, Revenue Targets For 2025 (RTTNews)
06.03.23	Roche receives FDA approval of label expansion for VENTANA PD-L1 (SP263) Assay to identify patients with locally advanced and metastatic non-small cell lung cancer eligible for Libtayo (PR Newswire)
28.02.23	Roche joins forces with the U.S. Centers for Disease Control and Prevention to strengthen laboratory systems in the fight against the HIV and tuberculosis epidemics (PR Newswire)
27.02.23	Rogers Enters Into Agreement With Starboard; Appoints Two Independent Directors (RTTNews)
16.02.23	Rogers To Reduce 7% Workforce Through Businesses Divestment (RTTNews)
09.02.23	Roche, Janssen Biotech To Advance Personalised Healthcare Through Companion Diagnostics (RTTNews)
09.02.23	Roche expands collaboration with Janssen to advance personalised healthcare through companion diagnostics (PR Newswire)
30.01.23	Jana Care to Enter Collaboration with Roche to Develop and Distribute Blood Testing Platform to Improve Remote Care for Patients With Chronic Kidney and Heart Disease (PR Newswire)
15.12.22	New Survey Shows Many Americans Are Confused by Testing Options for COVID-19 and Flu (PR Newswire)
05.12.22	Roche Announces Brad Moore as President and CEO of Roche Diagnostics North America (PR Newswire)
15.11.22	Jnana Therapeutics Announces Second Collaboration with Roche to Address Challenging-to-Drug Targets in Cancer, Immune-Mediated and Neurological Diseases (PR Newswire)
15.11.22	Roche receives FDA approval for VENTANA FOLR1 (FOLR1-2.1) RxDx Assay as the first IHC-based companion diagnostic to identify ovarian cancer patients eligible for ELAHERE (PR Newswire)
10.11.22	Roche launches Pilot brand, expands retail channels for COVID-19 At-Home Test (PR Newswire)
04.11.22	Roche introduces the navify brand for its digital health solutions at HLTH 2022 (PR Newswire)
30.09.22	DuPont, Rogers Provide Update On Pending Merger (RTTNews)
30.09.22	DuPont and Rogers Provide Update on Pending Merger (PR Newswire)
09.09.22	Roche's VENTANA PD-L1 (SP263) Assay receives CE IVD approval to identify patients with locally advanced and metastatic non-small cell lung cancer eligible for Libtayo (PR Newswire)
24.08.22	Roche's VENTANA PD-L1 (SP263) test gains CE label expansion as a companion diagnostic to identify non-small cell lung cancer patients eligible for Tecentriq (PR Newswire)
22.08.22	Roche launches COVID-19 test that detects and differentiates the emerging variant of interest BA.2.75 (PR Newswire)
11.08.22	Roche receives FDA approval for VENTANA MMR RxDx Panel to identify dMMR solid tumour patients and pMMR endometrial cancer patients eligible for KEYTRUDA (PR Newswire)
05.04.22	Roche to showcase the future of diagnostic solutions at EuroMedLab, 10 to 14 April 2022 Munich at ICM International Congress Center (PR Newswire)
25.03.22	Roche announces collaboration with Bristol Myers Squibb to advance personalised healthcare through digital pathology solutions (PR Newswire)
23.02.22	Roche expands the COVID-19 PCR test portfolio to the new cobas 5800 System in countries accepting the CE Mark (PR Newswire)
08.02.22	DuPont Reports Fourth Quarter and Full Year 2021 Results (PR Newswire)
17.12.21	Roche receives CE mark for the use of saliva samples with cobas SARS-CoV-2 Qualitative test on cobas 6800/8800 Systems (PR Newswire)
15.12.21	Roche launches the first infectious disease tests and cobas omni Utility Channel for use on the cobas 5800 System in countries accepting the CE Mark (PR Newswire)
07.12.21	Roche announces the release of its newest artificial intelligence based digital pathology algorithms to aid pathologists in evaluation of breast cancer markers, Ki-67, ER and PR (PR Newswire)
02.11.21	Rogers Q3 Results Rise, Adj. EPS, Sales Miss Estimates; To Be Bought By DuPont In $5.2 Bln Cash Deal (RTTNews)
02.11.21	DuPont Cuts FY21 Earnings, Sales View Below Market; To Buy Rogers Corp. For $5.2 Bln - Quick Facts (RTTNews)
02.11.21	DuPont Reports Third Quarter 2021 Results (PR Newswire)
02.11.21	DuPont Announces Strategic Actions to Enhance Portfolio for Near and Long-term Value Creation (PR Newswire)
18.10.21	Roche announces collaboration with Ibex Medical Analytics to develop artificial intelligence-based digital pathology applications for improved patient care (PR Newswire)
08.10.21	Rogers Corp. Buys Silicone Engineering For Undisclosed Sum (RTTNews)
07.09.21	NeuExcell Therapeutics and Spark Therapeutics Announce Research Collaboration Agreement to Develop a Novel Gene Therapy for Huntington's Disease (PR Newswire)
18.06.21	Roche SARS-CoV-2 molecular test granted first FDA Emergency Use Authorization for PCR testing of both symptomatic and asymptomatic individuals at the point of care (PR Newswire)
18.06.21	Roche SARS-CoV-2 molecular test granted first FDA Emergency Use Authorization for PCR testing of both symptomatic and asymptomatic individuals at the point of care (PR Newswire)
10.02.21	Rogers Reports Fire In S. Korea Plant; No Reported Injuries (RTTNews)
21.02.20	Rogers Slips To Loss In Q4 (RTTNews)
19.06.18	University of Missouri School of Medicine, Roche collaborate on first US implementation of tumor board software that improves treatment decision process for cancer patients (PR Newswire)
11.06.18	Roche introduces first self-testing device for Warfarin monitoring with built in Bluetooth® technology (PR Newswire)

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Logitech Intl	71.38	1.88 %	K V
UBS Group	28.06	1.41 %	K V
Part Grp Hldg	1’265.50	0.92 %	K V
ABB	49.45	0.88 %	K V
Swiss Re	129.70	0.78 %	K V
Nestle	76.42	0.08 %	K V
Alcon	78.06	0.08 %	K V
Givaudan	3’872.00	-0.21 %	K V
CieFinRichemont	121.50	-0.33 %	K V
Sonova Hldg	301.20	-0.92 %	K V

mehr

22.11.24		Freitagshandel in New York: Dow Jones zum Start des Freitagshandels fester
21.11.24		Starker Wochentag in New York: Dow Jones-Anleger greifen nachmittags zu
21.11.24		Donnerstagshandel in New York: Dow Jones mit Gewinnen
12.11.24		Handel in New York: S&P 500 letztendlich in der Verlustzone
12.11.24		Zurückhaltung in New York: NASDAQ 100 schlussendlich mit Abgaben
12.11.24		Dow Jones-Handel aktuell: Dow Jones beendet den Dienstagshandel mit Verlusten
12.11.24		Schwacher Wochentag in New York: S&P 500 fällt am Dienstagnachmittag zurück
12.11.24		Anleger in New York halten sich zurück: Dow Jones schwächelt am Nachmittag